Syros Pharmaceuticals (SYRS)
(Real Time Quote from BATS)
$1.55 USD
-0.07 (-4.03%)
Updated Aug 15, 2024 11:36 AM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Syros Pharmaceuticals, Inc. [SYRS]
Reports for Purchase
Showing records 221 - 223 ( 223 total )
Company: Syros Pharmaceuticals, Inc.
Industry: Unclassified
2Q, SY-1425 Ph 2 Study Enrollment Initiated, Reiterate OP
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Syros Pharmaceuticals, Inc.
Industry: Unclassified
Initiating Coverage with an OUTPERFORM Rating - $18 PT; A New Frontier in Gene Regulation
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Syros Pharmaceuticals, Inc.
Industry: Unclassified
The Potemkin Pipeline; Initiating With Neutral and $10 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A